TuHURA Biosciences Stock Forward View - Simple Regression
| HURA Stock | 0.52 0.02 3.70% |
TuHURA Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast TuHURA Biosciences stock prices and determine the direction of TuHURA Biosciences's future trends based on various well-known forecasting models. We suggest always using this module together with an analysis of TuHURA Biosciences' historical fundamentals, such as revenue growth or operating cash flow patterns.
The RSI of TuHURA Biosciences' share price is below 30 at this time. This usually indicates that the stock is becoming oversold or undervalued. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling TuHURA Biosciences, making its price go up or down. Momentum 24
Sell Stretched
Oversold | Overbought |
EPS Estimate Next Quarter (0.12) | EPS Estimate Current Year (0.65) | EPS Estimate Next Year (0.43) | Wall Street Target Price 12.0833 | EPS Estimate Current Quarter (0.14) |
Using TuHURA Biosciences hype-based prediction, you can estimate the value of TuHURA Biosciences from the perspective of TuHURA Biosciences response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Regression forecasted value of TuHURA Biosciences on the next trading day is expected to be 0.19 with a mean absolute deviation of 0.23 and the sum of the absolute errors of 13.99. TuHURA Biosciences after-hype prediction price | USD 0.39 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of TuHURA Biosciences to cross-verify your projections. TuHURA Biosciences Additional Predictive Modules
Most predictive techniques to examine TuHURA price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for TuHURA using various technical indicators. When you analyze TuHURA charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
TuHURA Biosciences Simple Regression Price Forecast For the 4th of February
Given 90 days horizon, the Simple Regression forecasted value of TuHURA Biosciences on the next trading day is expected to be 0.19 with a mean absolute deviation of 0.23, mean absolute percentage error of 0.07, and the sum of the absolute errors of 13.99.Please note that although there have been many attempts to predict TuHURA Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that TuHURA Biosciences' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
TuHURA Biosciences Stock Forecast Pattern
| Backtest TuHURA Biosciences | TuHURA Biosciences Price Prediction | Research Analysis |
TuHURA Biosciences Forecasted Value
In the context of forecasting TuHURA Biosciences' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. TuHURA Biosciences' downside and upside margins for the forecasting period are 0.01 and 7.43, respectively. We have considered TuHURA Biosciences' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of TuHURA Biosciences stock data series using in forecasting. Note that when a statistical model is used to represent TuHURA Biosciences stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 117.2204 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.2256 |
| MAPE | Mean absolute percentage error | 0.2281 |
| SAE | Sum of the absolute errors | 13.9866 |
Predictive Modules for TuHURA Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as TuHURA Biosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.TuHURA Biosciences After-Hype Price Density Analysis
As far as predicting the price of TuHURA Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in TuHURA Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of TuHURA Biosciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
TuHURA Biosciences Estimiated After-Hype Price Volatility
In the context of predicting TuHURA Biosciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on TuHURA Biosciences' historical news coverage. TuHURA Biosciences' after-hype downside and upside margins for the prediction period are 0.02 and 7.59, respectively. We have considered TuHURA Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
TuHURA Biosciences is very risky at this time. Analysis and calculation of next after-hype price of TuHURA Biosciences is based on 3 months time horizon.
TuHURA Biosciences Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as TuHURA Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading TuHURA Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with TuHURA Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
2.27 | 7.24 | 0.14 | 0.02 | 10 Events / Month | 8 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.52 | 0.39 | 25.00 |
|
TuHURA Biosciences Hype Timeline
TuHURA Biosciences is currently traded for 0.52. The entity has historical hype elasticity of -0.14, and average elasticity to hype of competition of -0.02. TuHURA is projected to decline in value after the next headline, with the price expected to drop to 0.39. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -25.0%, whereas the daily expected return is currently at -2.27%. The volatility of related hype on TuHURA Biosciences is about 80444.44%, with the expected price after the next announcement by competition of 0.50. About 36.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.92. Some equities with similar Price to Book (P/B) outperform the market in the long run. TuHURA Biosciences recorded a loss per share of 0.74. The entity had not issued any dividends in recent years. The firm had 1:35 split on the 18th of October 2024. Given the investment horizon of 90 days the next projected press release will be in about 10 days. Check out Historical Fundamental Analysis of TuHURA Biosciences to cross-verify your projections.TuHURA Biosciences Related Hype Analysis
Having access to credible news sources related to TuHURA Biosciences' direct competition is more important than ever and may enhance your ability to predict TuHURA Biosciences' future price movements. Getting to know how TuHURA Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how TuHURA Biosciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SEER | Seer Inc | (0.02) | 6 per month | 0.00 | (0.24) | 3.28 | (3.00) | 6.43 | |
| VTGN | VistaGen Therapeutics | (0.06) | 16 per month | 0.00 | (0.14) | 7.61 | (12.80) | 96.59 | |
| IRD | Opus Genetics | (0.04) | 8 per month | 4.16 | 0.07 | 7.62 | (7.41) | 26.50 | |
| AGEN | Agenus Inc | 0.11 | 10 per month | 0.00 | (0.10) | 6.63 | (6.79) | 30.06 | |
| CGTX | Cognition Therapeutics | 0.17 | 9 per month | 0.00 | (0.08) | 8.89 | (8.55) | 25.11 | |
| MCRB | Seres Therapeutics | (0.14) | 12 per month | 6.80 | (0.0009) | 9.13 | (7.64) | 54.10 | |
| SPRO | Spero Therapeutics | (0.14) | 8 per month | 0.00 | (0.05) | 3.59 | (5.04) | 13.07 | |
| ABOS | Acumen Pharmaceuticals | (0.04) | 7 per month | 4.46 | 0.05 | 9.94 | (7.18) | 37.58 | |
| TVGN | Tevogen Bio Holdings | 0.01 | 9 per month | 0.00 | (0.16) | 10.00 | (8.89) | 26.81 | |
| INO | Inovio Pharmaceuticals | 0.06 | 9 per month | 0.00 | (0.11) | 6.38 | (6.80) | 36.52 |
Other Forecasting Options for TuHURA Biosciences
For every potential investor in TuHURA, whether a beginner or expert, TuHURA Biosciences' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. TuHURA Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in TuHURA. Basic forecasting techniques help filter out the noise by identifying TuHURA Biosciences' price trends.TuHURA Biosciences Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with TuHURA Biosciences stock to make a market-neutral strategy. Peer analysis of TuHURA Biosciences could also be used in its relative valuation, which is a method of valuing TuHURA Biosciences by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
TuHURA Biosciences Market Strength Events
Market strength indicators help investors to evaluate how TuHURA Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading TuHURA Biosciences shares will generate the highest return on investment. By undertsting and applying TuHURA Biosciences stock market strength indicators, traders can identify TuHURA Biosciences entry and exit signals to maximize returns.
TuHURA Biosciences Risk Indicators
The analysis of TuHURA Biosciences' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in TuHURA Biosciences' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting tuhura stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.33 | |||
| Standard Deviation | 6.96 | |||
| Variance | 48.47 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for TuHURA Biosciences
The number of cover stories for TuHURA Biosciences depends on current market conditions and TuHURA Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that TuHURA Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about TuHURA Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
TuHURA Biosciences Short Properties
TuHURA Biosciences' future price predictability will typically decrease when TuHURA Biosciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of TuHURA Biosciences often depends not only on the future outlook of the potential TuHURA Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. TuHURA Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 18.7 M | |
| Cash And Short Term Investments | 12.7 M |
Check out Historical Fundamental Analysis of TuHURA Biosciences to cross-verify your projections. For information on how to trade TuHURA Stock refer to our How to Trade TuHURA Stock guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TuHURA Biosciences. Market participants price TuHURA higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive TuHURA Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding TuHURA Biosciences requires distinguishing between market price and book value, where the latter reflects TuHURA's accounting equity. The concept of intrinsic value—what TuHURA Biosciences' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push TuHURA Biosciences' price substantially above or below its fundamental value.
Please note, there is a significant difference between TuHURA Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if TuHURA Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, TuHURA Biosciences' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.